Coalition of explainable artificial intelligence and quantum computing in precision medicine
Abstract
This survey examines the convergence of Explainable Artificial Intelligence (XAI) and Quantum Computing (QC) toward precision medicine. We review developments from 2018 to 2025, summarizing quantum algorithms, quantum-machine-learning models and XAI techniques applied to drug discovery, disease diagnosis, patient monitoring and biomarker identification. We introduce a taxonomy of hybrid and quantum-explainable approaches, evaluate NISQ hardware and encoding constraints, and compare interpretability methods (SHAP, LIME, QSHAP, QLRP, TSBA). Two case studies (doxorubicin cardiotoxicity prediction and pre-symptomatic IBD flare forecasting) demonstrate hybrid variational-quantum pipelines wrapped with SHAP-based explanations. We identify practical barriers (noise, data encoding, regulation, privacy) and outline research directions to benchmark clinical quantum advantage and develop scalable, transparent QXAI frameworks. The survey aims to guide interdisciplinary efforts toward trustworthy, scalable quantum-enabled precision healthcare.
Read the paper
Related studies
- In silico toxicology protocols
- QM7-X, a comprehensive dataset of quantum-mechanical properties spanning the chemical space of small organic molecules
- Quantum Informed Machine-Learning Potentials for Molecular Dynamics Simulations of CO2's Chemisorption and Diffusion in Mg-MOF-74
- In-silico strategies in nano-drug design: Bridging nanomaterials and pharmacological applications
- mRNA codon optimization with quantum computers
- The computational power of the human brain
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.